Skip to main content

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Active, not recruiting · Phase 2 · NCT06843590

Conditions: Idiopathic Hypersomnia

At a glance

Research payments reported, 2025
$2.1M
U.S. investigators named
36
Sites paid
36
Planned or actual enrollment
126

About the trial

Sponsor
Alkermes, Inc.
Tested
ALKS 2680 (drug), Placebo (drug)
Dates
Started 2025-05-22; completion 2026-11
Results posted
Not yet

The purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets

From ClinicalTrials.gov, last updated 2026-09-25. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Alkermes, Inc. reported $2.1M in research payments for this study in 2025 (1,443 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Intrepid Research, LLC. $298,958
  • Bogan Sleep Consultants, LLC $151,211
  • Tricoastal Narcolepsy and Sleep Disorders Center, PLLC. $149,336
  • The Board of Trustees of the Leland Stanford Junior University $137,978
  • Mayo Clinic Hospital, AZ $133,114
  • Teradan Clinical Trials $132,906
  • UCSF Langley Porter Psychiatric Hospital and Clinics, CA $129,524
  • Delta Waves Sleep Disorders and Research Center $114,660
  • Sound Asleep Research, Inc. $113,202
  • Advanced Respiratory and Sleep Medicine, PLLC $99,364
  • The Board of Regents of the University of Wisconsin System $80,252
  • Clinical Site PArtners, LLC. $73,156
  • Sleep Practitioners, LLC $71,365
  • Clinical Research Institute $58,265
  • Pharmadev Clinical Research Institute, LLC $56,225
  • Pharmaseek, LLC. dba Wcg Site Network $41,450
  • Respiratory Specialists $34,982
  • Bryan Medical Center, NE $30,390
  • Thomas Jefferson University $28,969
  • Cleveland Clinic, OH $28,869
  • Osf Heart of Mary Medical Center, IL $22,935
  • Preferred Research PArtners $22,584
  • Neurotrials Research, Inc. $19,573
  • Cullman Clinical Trials, LLC. $18,497
  • Sleep Therapy & Research Center $17,471
  • Neuroscience Research Center, LLC. $13,618
  • Research Carolina Elite, LLC. $9,585
  • Santa Monica Clinical Trials $7,305
  • Futuresearch Trials of Neurology, LLC. $6,937
  • Beth Israel Deaconess Medical Center, MA $6,551
  • Patient First MD $4,385
  • Serenity Research Center, LLC. $4,309
  • Comprehensive Sleep Medicine Associates Csma $2,739
  • University of Kansas Medical Center Research Institute, Inc. $2,739
  • Geisinger Clinic $2,739
  • Sds Clinical Trials, Inc. $2,587

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.